Skip to main content
logo
Beijing Biostar Pharmaceuticals Co., Ltd. (HKG:2563)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
3.650
+0.020 (0.55%)
Aug 27, 2026, 2:47 PM HKT

HKG:2563 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
55.2133.3671.8766.6432.8271.06
Revenue Growth
65.48%-53.57%7.85%103.03%-53.82%-
Gross Profit
51.0730.7462.0546.8323.8866.89
Operating Income
-98.19-139.6-169.77-216.47-194.23-293.79
Net Income
-103.99-131.44-143.78-189.64-160.51-278.14
Earnings Per Share
--0.36-0.41-0.54-0.46-0.79
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
470.41456.77572.63576.02729.26805.37
Total Debt
1.41.971.180.91.91.14
Net Cash (Debt)
469.01454.79571.44575.12727.36804.23
Net Cash Growth
3.13%-20.41%-0.64%-20.93%-9.56%-8.46%
Net Cash Per Share
-1.251.631.642.082.30

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
--151.52-112.59-150.78-79.44-78.77
Capital Expenditures
--5.42-40.8-27.84-31.86-11.06
Free Cash Flow
--156.94-153.39-178.62-111.3-89.83
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
92.50%92.13%86.35%70.27%72.76%94.13%
Operating Margin
-177.84%-418.41%-236.23%-324.87%-591.81%-413.42%
Pretax Margin
-188.34%-393.94%-200.06%-284.60%-489.06%-391.40%
Profit Margin
-188.34%-393.94%-200.06%-284.60%-489.06%-391.40%
FCF Margin
--470.38%-213.45%-268.05%-339.12%-126.41%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
20.7648.0293.92---